Moreover, preclinical studies focusing on the role of the gut microenvironment have shown that gut-derived endocrine factors may reduce microglial activation and hypothalamic inflammatory processes [20] and amplify the catabolic actions of exogenous leptin in obesity [21,22]. The gene discussed is LEP; the disease is Obesity.